The Association Between Serum Carnitine Level, Glucose Regulation, Body Fat and Nutrient Intake in Diabetic Individuals

1Mamoulakis D, Galanakis E, Dionyssopoulou E, Evangeliou A, Sbyrakis S. Carnitine deficiency in children and adolescents with type 1 diabetes. Journal of Diabetes and Its Complications, 2004;18(5), 271-274.Mamoulakis D Galanakis E Dionyssopoulou E Evangeliou A Sbyrakis S Carnitine deficiency in children and adolescents with type 1 diabetes Journal of Diabetes and Its Complications 200418 5 271 27410.1016/S1056-8727(03)00091-6Search in Google Scholar

2Gülçin İ. Antioxidant and antiradical activities of L-carnitine. Life Sciences, 2006;78(8), 803-811Gülçin İ Antioxidant and antiradical activities of L-carnitine Life Sciences 200678 8 803 81110.1016/j.lfs.2005.05.103Search in Google Scholar

3Deniz G. Karnitin: sentez, metabolizma, fonksiyon ve iskemik kalpte terapötik önemi. Turkiye Klinikleri Journal of Medical Sciences, 1999;19(1), 5-62.Deniz G Karnitin: sentez, metabolizma, fonksiyon ve iskemik kalpte terapötik önemi Turkiye Klinikleri Journal of Medical Sciences 199919 1 5 62Search in Google Scholar

4Yavuz H, Kurtoğlu F. Biyokimyasal özellikleri ile L-karnitin. Journal of The Faculty of Veterinary Medicine, İstanbul University, 2012;38(2), 207-218.Yavuz H Kurtoğlu F Biyokimyasal özellikleri ile L-karnitin Journal of The Faculty of Veterinary Medicine, İstanbul University 201238 2 207 218Search in Google Scholar

5Mahmood M D, Al-Youzbaki W B, Aziz B N. Effects of L-carnitine on glycemic control, serum insulin and c-peptide level in alloxan-induced diabetic rabbit. Pharmacie Globale, 2014;5(2), 1.Mahmood M D Al-Youzbaki W B Aziz B N Effects of L-carnitine on glycemic control, serum insulin and c-peptide level in alloxan-induced diabetic rabbit Pharmacie Globale 20145 2 1Search in Google Scholar

6Tamamoğullari N, Siliğ Y, İçağasioğlu S, Atalay A. Carnitine deficiency in diabetes mellitus complications. Journal of Diabetes and Its Complications, 1999;13(5), 251-253.Tamamoğullari N Siliğ Y İçağasioğlu S Atalay A Carnitine deficiency in diabetes mellitus complications Journal of Diabetes and Its Complications 199913 5 251 25310.1016/S1056-8727(99)00052-5Search in Google Scholar

7Sütken E, Uslu S, Aral E, Özdemir F, Alataş, Ö. Diabetik sıçanlarda L-karnitin, n-asetil-β-d-glukozaminidaz düzeyleri ve erken diabetik nefropatide plazma fibronektinin rolü. Anadolu University Journal of Science And Technology, 2009;10:2Sütken E Uslu S Aral E Özdemir F Alataş Ö Diabetik sıçanlarda L-karnitin, n-asetil-β-d-glukozaminidaz düzeyleri ve erken diabetik nefropatide plazma fibronektinin rolü Anadolu University Journal of Science And Technology 2009102Search in Google Scholar

8Korkmaz S, Yıldız G, Kılıçlı F, Yılmaz A, Aydın H, İçağasıoğlu S, Candan F. Düşük L-karnitin düzeyleri: Tip 2 diyabetes mellitus olgularında noktürnal kan basıncı değişikliklerinin bir nedeni olabilir mi?. The Anatolian Journal of Cardiology, 2011;1, 57-63.Korkmaz S Yıldız G Kılıçlı F Yılmaz A Aydın H İçağasıoğlu S Candan F Düşük L-karnitin düzeyleri: Tip 2 diyabetes mellitus olgularında noktürnal kan basıncı değişikliklerinin bir nedeni olabilir mi? The Anatolian Journal of Cardiology 20111 57 63Search in Google Scholar

9Ringseis R, Keller J, Eder K. Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency. European Journal of Nutrition, 2012;51(1), 1-18.Ringseis R Keller J Eder K Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency European Journal of Nutrition 201251 1 1 1810.1007/s00394-011-0284-2Search in Google Scholar

10Yoon K H, Lee J. H, Kim J W, Cho J H, Choi Y H, Ko S H, Son H Y. Epidemic obesity and type 2 diabetes in Asia. The Lancet, 2006;368(9548), 1681-1688.Yoon K H Lee J H Kim J W Cho J H Choi Y H Ko S H Son H Y Epidemic obesity and type 2 diabetes in Asia. The Lancet 2006368 9548 1681 168810.1016/S0140-6736(06)69703-1Search in Google Scholar

11Reda E, D’iddio S, Nicolai R, Benatti P, Calvani M. The carnitine system and body composition. Acta diabetologica, 2003;40(1), s106-s113.Reda E D’iddio S Nicolai R Benatti P Calvani M The carnitine system and body composition Acta diabetologica 200340 1 s106 s11310.1007/s00592-003-0040-z14618447Search in Google Scholar

12Peluso G, Mingrone G, Barbarisi A, Petillo O, Greco A V, Indiveri C, Calvani M. Decreased skeletal muscle carnitine translocase impairs utilization of fatty acids in insulin-resistant human muscle. Front Biosci, 2002;7, A109-A116.Peluso G Mingrone G Barbarisi A Petillo O Greco A V Indiveri C Calvani M Decreased skeletal muscle carnitine translocase impairs utilization of fatty acids in insulin-resistant human muscle Front Biosci 20027 A109 A11610.2741/A74511991847Search in Google Scholar

13Mingrone G, Greco A V, Capristo E, Benedetti G, Giancaterini A, Gaetano A D, Gasbarrini G. L-carnitine improves glucose disposal in type 2 diabetic patients. Journal of the American College of Nutrition, 1999;18(1), 77-82.Mingrone G Greco A V Capristo E Benedetti G Giancaterini A Gaetano A D Gasbarrini G L-carnitine improves glucose disposal in type 2 diabetic patients Journal of the American College of Nutrition 199918 1 77 8210.1080/07315724.1999.1071883010067662Search in Google Scholar

14Derosa G, Maffioli P, Ferrari I, D’Angelo A, Fogari E, Palumbo I, Randazzo S, Cicero A F. Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients. Endocrine Journal, 2009;57(9), 777-786.Derosa G Maffioli P Ferrari I D’Angelo A Fogari E Palumbo I Randazzo S Cicero A F Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients Endocrine Journal 200957 9 777 78610.1507/endocrj.K10E-04920683173Search in Google Scholar

15Sirtori C R, Calabresi L, Ferrara S, Pazzucconi F, Bondioli A, Baldassarre D, Birreci A, Koverech A. L-carnitine reduces plasma lipoprotein (a) levels in patients with hyper Lp (a). Nutrition, Metabolism and Cardiovascular Diseases: 2000;10(5), 247-251.Sirtori C R Calabresi L Ferrara S Pazzucconi F Bondioli A Baldassarre D Birreci A Koverech A L-carnitine reduces plasma lipoprotein (a) levels in patients with hyper Lp (a) Nutrition, Metabolism and Cardiovascular Diseases 200010 5 247 251Search in Google Scholar

16Malaguarnera M, Vacante M, Avitabile T, Malaguarnera M, Cammalleri L, Motta M. L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes. The American Journal of Clinical Nutrition, 2009;89(1), 71-76.Malaguarnera M Vacante M Avitabile T Malaguarnera M Cammalleri L Motta M L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes The American Journal of Clinical Nutrition 200989 1 71 7610.3945/ajcn.2008.2625119056606Search in Google Scholar

17Gonzalez-Ortiz M, Hernandez-Gonzalez S O, Hernandez-Salazar E, Martinez-Abundis E. Effect of oral L-carnitine administration on insulin sensitivity and lipid profile in type 2 diabetes mellitus patients. Annals of Nutrition and Metabolism, 2008;52(4), 335-338.Gonzalez-Ortiz M Hernandez-Gonzalez S O Hernandez-Salazar E Martinez-Abundis E Effect of oral L-carnitine administration on insulin sensitivity and lipid profile in type 2 diabetes mellitus patients Annals of Nutrition and Metabolism 200852 4 335 33810.1159/00015148818714152Search in Google Scholar

18Bebis Nutrition Data Base Software Data Base. The German Food Code and Nutrient Data Base (BLS II.3, 1999) with additions from USDA-sr and other sources, Istanbul, Turkey. 2004Bebis Nutrition Data Base Software Data Base The German Food Code and Nutrient Data Base (BLS II.3 1999 with additions from USDA-sr and other sources Istanbul, Turkey 2004Search in Google Scholar

19Wallace T M, Levy J C, Matthews D R. Use and abuse of HOMA modeling. Diabetes Care, 2004;27(6), 1487-1495.Wallace T M Levy J C Matthews D R Use and abuse of HOMA modeling Diabetes Care 200427 6 1487 149510.2337/diacare.27.6.148715161807Search in Google Scholar

20Bouchouirab F Z, Fortin M, Noll C, Dubé J, Carpentier A C. Plasma palmitoyl-carnitine (AC16: 0) is a marker of increased postprandial nonesterified incomplete fatty acid oxidation rate in adults with type 2 diabetes. Canadian journal of diabetes, 2018;42(4), 382-388.Bouchouirab F Z Fortin M Noll C Dubé J Carpentier A C Plasma palmitoyl-carnitine (AC16: 0) is a marker of increased postprandial nonesterified incomplete fatty acid oxidation rate in adults with type 2 diabetes Canadian journal of diabetes 201842 4 382 38810.1016/j.jcjd.2017.09.00229129455Search in Google Scholar

21Bene J, Hadzsiev K, Melegh B. Role of carnitine and its derivatives in the development and management of type 2 diabetes. Nutrition & diabetes, 2018;8(1), 1-10.Bene J Hadzsiev K Melegh B Role of carnitine and its derivatives in the development and management of type 2 diabetes Nutrition & diabetes 20188 1 1 1010.1038/s41387-018-0017-1585683629549241Search in Google Scholar

22De Palo E, Gatti R, Sicolo N, Padovan D, Vettor R, Federspil G. Plasma and urine free L-carnitine in human diabetes mellitus. Acta Diabetologica, 1981;18(1), 91-95.De Palo E Gatti R Sicolo N Padovan D Vettor R Federspil G Plasma and urine free L-carnitine in human diabetes mellitus Acta Diabetologica 198118 1 91 9510.1007/BF020561107211090Search in Google Scholar

23American Diabetes Association (ADA). Standards of medical care in diabetes-2016, Diabetes Care, 2016;39(1).American Diabetes Association (ADA) Standards of medical care in diabetes-2016 Diabetes Care 201639 110.2337/dc16-S00326696680Search in Google Scholar

24Köseoğlu Ö. Tip 2 diyabetik bireylerde beslenme eğitiminin diyabet durumu ve beslenme alışkanlıklarına etkisi. Yayımlanmamış Yüksek Lisans Tezi, Başkent Üniversitesi Sağlık Bilimleri Enstitüsü, Ankara. 2015.Köseoğlu Ö Tip 2 diyabetik bireylerde beslenme eğitiminin diyabet durumu ve beslenme alışkanlıklarına etkisi. Yayımlanmamış Yüksek Lisans Tezi, Başkent Üniversitesi Sağlık Bilimleri Enstitüsü, Ankara 2015Search in Google Scholar

25Wolfram T, Ismail-Beigi F. Efficacy of high-fiber diets in the management of type 2 diabetes mellitus. Endocrine Practice, 2010;17(1), 132-142.Wolfram T Ismail-Beigi F Efficacy of high-fiber diets in the management of type 2 diabetes mellitus Endocrine Practice 201017 1 132 14210.4158/EP10204.RA20713332Search in Google Scholar

26Marshall J A, Bessesen D H, Hamman R F. High saturated fat and low starch and fibre are associated with hyperinsulinaemia in a non-diabetic population: the San Luis Valley Diabetes Study. Diabetologia, 1997;40(4), 430-438Marshall J A Bessesen D H Hamman R F High saturated fat and low starch and fibre are associated with hyperinsulinaemia in a non-diabetic population: the San Luis Valley Diabetes Study Diabetologia 199740 4 430 43810.1007/s0012500506979112020Search in Google Scholar

27Salmeron J, Hu F B, Manson J E, Stampfer M J, Colditz G A, Rimm E B, Willett W C. Dietary fat intake and risk of type 2 diabetes in women. The American Journal of Clinical Nutrition, 2001;73(6), 1019-1026Salmeron J Hu F B Manson J E Stampfer M J Colditz G A Rimm E B Willett W C Dietary fat intake and risk of type 2 diabetes in women The American Journal of Clinical Nutrition 200173 6 1019 102610.1093/ajcn/73.6.101911382654Search in Google Scholar

28Özpak Akkuş Ö. Comparison of serum vitamin D, calcium and magnesium levels with nutritional habits among type 2 diabetic and nondiabetic ındividuals. Başkent University, Institute of Health Sciences, Nutrition and Dietetic Program, PhD Thesis, Ankara, 2015.Özpak Akkuş Ö Comparison of serum vitamin D, calcium and magnesium levels with nutritional habits among type 2 diabetic and nondiabetic ındividuals. Başkent University, Institute of Health Sciences, Nutrition and Dietetic Program, PhD Thesis Ankara 201510.17362/DBHAD.2015310325Search in Google Scholar

29El-Badry A M, Graf R, Clavien P A. Omega 3–Omega 6: What is right for the liver?. Journal of Hepatology, 2007;47(5), 718-725.El-Badry A M Graf R Clavien P A Omega 3–Omega 6: What is right for the liver? Journal of Hepatology 200747 5 718 72510.1016/j.jhep.2007.08.00517869370Search in Google Scholar

30Reuter S E, Evans A M. Carnitine and acylcarnitines. Clinical Pharmacokinetics, 2012;51(9), 553-572Reuter S E Evans A M Carnitine and acylcarnitines Clinical Pharmacokinetics 201251 9 553 57210.1007/BF0326193122804748Search in Google Scholar

31Derosa G, Maffioli P, Ferrari I, D’Angelo A. Fogari E, Palumbo I, Cicero A F. Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients. Endocrine Journal, 2010;57(9), 777-786.Derosa G Maffioli P Ferrari I D’Angelo A Fogari E Palumbo I Cicero A F Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients. Endocrine Journal 201057 9 777 78610.1507/endocrj.K10E-04920683173Search in Google Scholar

32Müller D M, Seim H, Kiess W, Richter T. Effects of oral L-carnitine supplementation on in vivo long-chain fatty acid oxidation in healthy adults. Metabolism-Clinical and Experimental, 2002;51(1), 1389-1391.Müller D M Seim H Kiess W Richter T Effects of oral L-carnitine supplementation on in vivo long-chain fatty acid oxidation in healthy adults Metabolism-Clinical and Experimental 200251 1 1389 139110.1053/meta.2002.3518112404185Search in Google Scholar

33Mun E G, Soh J R, Cha Y S. L-carnitine reduces obesity caused by high-fat diet in C57BL/6J mice. Food Science and Biotechnology, 2007;16(2), 58-63.Mun E G Soh J R Cha Y S L-carnitine reduces obesity caused by high-fat diet in C57BL/6J mice Food Science and Biotechnology 200716 2 58 63Search in Google Scholar

34Ramazani M, Qujeq D, Moazezi Z. Assessing the levels of L-carnitine and total antioxidant capacity in adults with newly diagnosed and long-standing type 2 diabetes. Canadian journal of diabetes, 2019;43(1), 46-50.Ramazani M Qujeq D Moazezi Z Assessing the levels of L-carnitine and total antioxidant capacity in adults with newly diagnosed and long-standing type 2 diabetes Canadian journal of diabetes 201943 1 46 5010.1016/j.jcjd.2018.03.00930026047Search in Google Scholar

35Talenezhad N, Mohammadi M, Ramezani-Jolfaie N, Mozaffari-Khosravi H, Salehi-Abargouei A. Effects of l-carnitine supplementation on weight loss and body composition: A systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis. Clinical nutrition ESPEN. 2020Talenezhad N Mohammadi M Ramezani-Jolfaie N Mozaffari-Khosravi H Salehi-Abargouei A Effects of l-carnitine supplementation on weight loss and body composition: A systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis Clinical nutrition ESPEN 202010.1016/j.clnesp.2020.03.00832359762Search in Google Scholar